MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Edesa Biotech, Inc. (EDSA)

Edesa Biotech, Inc. (EDSA)

|||

Balance Sheets Overview

Current Ratio
275.71%
Quick Ratio
275.71%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Accounts and other receivable
    • Prepaid expenses and other curre...
    • Long-term deposits
Liabilities Breakdown
    • Accumulated deficit
    • Authorized unlimited common shar...
    • Additional paid-in capital
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
10,332,520
10,003,683
12,051,748
10,792,172
Accounts and other receivable
228,051
216,468
431,325
642,866
Prepaid expenses and other current assets
219,707
197,576
234,414
77,838
Total current assets
10,780,278
10,417,727
12,717,487
11,512,876
Long-term deposits
39,120
39,921
40,572
39,966
Intangible asset, net
1,901,797
1,927,090
1,952,383
1,977,676
Right-of-use assets
-
-
-
0
Total assets
12,721,195
12,384,738
14,710,442
13,530,518
Accounts payable and accrued liabilities
3,910,041
2,187,921
756,163
1,078,536
Short-term right-of-use lease liabilities
-
-
-
0
Total current liabilities
3,910,041
2,187,921
756,163
1,078,536
Authorized unlimited common shares without par value issued and outstanding 8,885,719 common shares (september 30, 2025 -7,141,783)
62,416,047
58,932,825
57,899,593
54,515,421
Preferred stock, shares issued-Series A1Preferred Stock
1,203,914
1,166,517
1,129,530
1,092,133
Preferred stock, shares issued-Series B1Preferred Stock
7,208,266
7,208,266
8,168,063
8,168,063
Additional paid-in capital
16,037,835
15,526,657
15,124,219
14,753,110
Accumulated other comprehensive loss
-158,541
-186,089
-171,086
-165,771
Accumulated deficit
-77,896,367
-72,451,359
-68,196,040
-65,910,974
Total shareholders' equity
8,811,154
10,196,817
13,954,279
12,451,982
Total liabilities and shareholders' equity
12,721,195
12,384,738
14,710,442
13,530,518
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$10,332,520 (-16.41%↓ Y/Y)Accounts and otherreceivable$228,051 (-20.47%↓ Y/Y)Prepaid expenses andother current assets$219,707 (95.02%↑ Y/Y)Total current assets$10,780,278 (-15.52%↓ Y/Y)Intangible asset, net$1,901,797 (-5.05%↓ Y/Y)Long-term deposits$39,120 (-3.97%↓ Y/Y)Total assets$12,721,195 (-14.07%↓ Y/Y)Total liabilities andshareholders' equity$12,721,195 (-14.07%↓ Y/Y)Total shareholders'equity$8,811,154 (-37.65%↓ Y/Y)Total currentliabilities$3,910,041 (481.27%↑ Y/Y)Accumulated deficit-$77,896,367 (-22.39%↓ Y/Y)Accumulated othercomprehensive loss-$158,541 (-28.81%↓ Y/Y)Authorized unlimitedcommon shares without...$62,416,047 (15.01%↑ Y/Y)Accounts payable andaccrued liabilities$3,910,041 (481.27%↑ Y/Y)Additional paid-in capital$16,037,835 (11.32%↑ Y/Y)Preferred stock, sharesissued-Series B1Preferred...$7,208,266 (-11.75%↓ Y/Y)Preferred stock, sharesissued-Series A1Preferred...$1,203,914 (14.14%↑ Y/Y)